|
1 Indications And Usage Sovaldi Is A Hepatitis C Virus (Hcv) Nucleotide Analog Ns5b Polymerase Inhibitor Indicated For The Treatment Of: Adult Patients With Genotype 1, 2, 3 Or 4 Chronic Hcv Infection Without Cirrhosis Or With Compensated Cirrhosis As A Component Of A Combination Antiviral Treatment Regimen. ( 1 ) Pediatric Patients 3 Years Of Age And Older With Genotype 2 Or 3 Chronic Hcv Infection Without Cirrhosis Or With Compensated Cirrhosis In Combination With Ribavirin. ( 1 ) Adult Patients: Sovaldi Is Indicated For The Treatment Of Adult Patients With Chronic Hepatitis C Virus (Hcv) Infection As A Component Of A Combination Antiviral Treatment Regimen [See Dosage And Administration (2.2) , And Clinical Studies (14) ] Genotype 1 Or 4 Infection Without Cirrhosis Or With Compensated Cirrhosis For Use In Combination With Pegylated Interferon And Ribavirin Genotype 2 Or 3 Infection Without Cirrhosis Or With Compensated Cirrhosis For Use In Combination With Ribavirin. Pediatric Patients: Sovaldi Is Indicated For The Treatment Of Chronic Hcv Genotype 2 Or 3 Infection In Pediatric Patients 3 Years Of Age And Older Without Cirrhosis Or With Compensated Cirrhosis For Use In Combination With Ribavirin [See Dosage And Administration (2.3) And Clinical Studies (14.5) ] .
|